Nephrocare Health Services opened lower at ₹608.10, compared with its previous close of ₹619.55. During today's session, the stock has traded between ₹601.05 and ₹624.20, with an average traded price of ₹612.84. It is currently showing a sideways intraday trend.
An investment of ₹10,000 made 1 year ago in Nephrocare Health Services is now worth
₹ 13,177.00
giving a profit of
₹ 3,177.00 (31.77%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+1.40 (+0.23%)
Day High
₹624.20
Day Low
₹601.05
Day Open
₹608.10
Prev Close
₹619.55
Volume
2,51,850
Value Traded
₹15.43 Cr
1W Return
-2.62%
1M Return
-18.87%
3M Return
-4.32%
6M Return
10.82%
1Y Return
31.77%
Market Cap (₹ Cr.)
6,244
PE Ratio
73.20
PB Ratio
5.58
Dividend Yield
-
ROE
6.88%
ROCE
13.46%
Book Value (₹)
111.03
Face Value (₹)
2.00
EPS (TTM)
3.19
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-2.62%
6 Week
-
1 Month
-18.87%
3 Month
-4.32%
9 Month
27.87%
Polar Capital raises Nephrocare stake to 8.31% via off-market deal
Polar Capital Funds PLC increased its aggregate stake in Nephrocare Health Services to 8.311%. The acquisition involved 2,549,478 shares purchased via off-market placing on September 24, 2026. Healthcare Opportunities Fund accounted for 2,545,719 of the total shares acquired. Total voting capital remained unchanged at 100,559,014 equity shares.
15 days agoNephrocare Health Services to host analyst meet in Mumbai on Sep 29
Nephrocare Health Services Limited scheduled an analyst meet for September 29, 2026. Event hosted by PL Capital at Trident BKC, Mumbai starting 1:00 pm IST. Discussions limited to publicly available information with no UPSI intended. Filing made under Regulation 30 of SEBI Listing Regulations.
21 days agoNephrocare consolidates Philippine subsidiaries to streamline operations
Board approves consolidation of Philippine step-down subsidiaries on September 18, 2026. Aimed at simplifying corporate structure and improving operational efficiency. No change in ultimate economic interest or control over Philippine operations. Transaction accounted for as common-control with no third-party involvement. Subject to regulatory approvals in India and the Philippines.
25 days agoNephrocare acquires Philippines dialysis assets for ₹10.25 crore
Nephrocare acquires Philippines dialysis assets for ₹10.25 crore. Deal executed on September 14, 2026, via overseas subsidiary. Assets located in Plaridel, Bulacan, Philippines. Seller Renal One Dialysis Corp is unrelated to promoters.
28 days agoNephrocare Health acquires Kazakhstan dialysis unit for ₹116.35 million
Nephrocare Health Services acquires 100% stake in Dialysis Center Almaty LLP. Aggregate consideration is approx ₹116.35 million (KZT 561.66 million). Target operates 34 dialysis machines in Kazakhstan. Last audited turnover for calendar year 2025 was approx ₹10.93 crore. Deal aims to expand international dialysis services network.
1mo agoNephrocare faces ₹14.79 crore tax demand in Uzbekistan over audit discrepancy
Nephrocare Health Services Central Asia LLC received a tax audit order from Uzbekistan authorities. Net additional tax assessment is ₹11.50 crore with a penalty of ₹3.29 crore. Total aggregate exposure stands at approximately ₹14.79 crore excluding interest. Dispute arises from revenue data discrepancies affecting tax exemption eligibility. Company expects no material impact and is evaluating legal remedies including appeal.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,910.60 | -3.00% | ₹32,069.20 | 60.51 | +23.39% | |
| ₹1,406.50 | -3.14% | ₹14,486.63 | 79.85 | +43.37% | |
| ₹534.75 | -0.71% | ₹11,090.05 | 54.95 | +7.22% | |
| ₹499.45 | -3.00% | ₹7,949.51 | 46.60 | +18.54% | |
| ₹532.70 | +0.05% | ₹1,728.01 | 17.74 | -35.43% | |
| ₹314.40 | +1.88% | ₹1,637.42 | 45.94 | +7.80% | |
| ₹1,519.60 | -5.58% | ₹1,304.22 | 24.59 | +16.72% | |
| ₹549.85 | +0.95% | ₹1,074.57 | 14.50 | -2.73% | |
| ₹283.00 | -0.35% | ₹900.24 | -34.71 | -8.71% | |
| ₹105.19 | -0.40% | ₹765.65 | 33.11 | +31.06% | |
| ₹232.55 | +0.24% | ₹568.63 | 22.52 | -19.25% | |
| ₹64.50 | +0.00% | ₹81.09 | 16.62 | -33.30% |
An investment of ₹10,000 made 1 year ago in Nephrocare Health Services is now worth
₹ 13,177.00
giving a profit of
₹ 3,177.00 (31.77%)
Note: Past profits do not guarantee future returns.
